GPT2 inhibits PHD2 (proline hydroxylase 2) activity, which is involved in the regulation of hypoxia-inducible factor-1α (HIF-1α) stability by decreasing α-KG levels in breast cancer cells. The gene discussed is HIF1A; the disease is breast carcinoma.